Patents by Inventor Arnaud Michel DIDIERLAURENT

Arnaud Michel DIDIERLAURENT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951161
    Abstract: Methods of inducing an immune response comprising at least two administrations of an adjuvanted immunogenic composition, wherein the second administration contains reduced amounts of antigen and adjuvant.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: April 9, 2024
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: William Ripley Ballou, Jr., Arnaud Michel Didierlaurent, Robbert Gerrit Van Der Most
  • Publication number: 20200306353
    Abstract: Methods of inducing an immune response comprising at least two administrations of an adjuvanted immunogenic composition, wherein the second administration contains reduced amounts of antigen and adjuvant.
    Type: Application
    Filed: March 11, 2020
    Publication date: October 1, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: William Ripley BALLOU, JR., Arnaud Michel DIDIERLAURENT, Robbert Gerrit VAN DER MOST
  • Patent number: 10624961
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition, wherein a lower dose is given in the second administration than in the first administration, and wherein the second administration may be unadjuvanted.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: April 21, 2020
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: William Ripley Ballou, Jr., Arnaud Michel Didierlaurent, Robbert Gerrit Van Der Most
  • Publication number: 20180360956
    Abstract: The invention provides a pro-resolving mediator for use in the reduction of reactogenicity induced by administration of a vaccine or immunogenic composition comprising at least an antigen, and vaccines or immunogenic compositions comprising such a pro-resolving mediator.
    Type: Application
    Filed: December 13, 2016
    Publication date: December 20, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Arnaud Michel DIDIERLAURENT, Caroline Christiane HERVE
  • Publication number: 20170136110
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition, wherein a lower dose is given in the second administration than in the first administration, and wherein the second administration may be unadjuvanted.
    Type: Application
    Filed: April 2, 2015
    Publication date: May 18, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: William Ripley BALLOU, JR., Arnaud Michel DIDIERLAURENT, Robbert Gerrit VAN DER MOST